Per Seest Jørgensen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Per Seest Jørgensen has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Carsten Tørholm
2 shared publicationsCarsten Sloth
1 shared publicationCharlotte Paltved
1 shared publicationEva Narvestad
1 shared publicationHelle Vibeke Berg
1 shared publicationKim Hansen
1 shared publication
Latest Publications
- 4 June 2007
- Vol. 169 (23) , 2201-4
[Treatment of patellofemoral arthritis with patello-femoral arthroplasties].
Patellofemoral arthritis is a common entity and patellofemoral arthroplasties have been performed since the 1970s. However, follow-up studies are few, and the optimal indication for the operation has yet to be established. This study concentrates on the gains in patient-reported quality of life parameters achieved by the operation. Of 26 patients operated with 31 Richards Model Patella II patellofemoral arthroplasties, 17 patients with 20 arthroplasties were available for clinical review using two subjective/objective scoring systems and one patient administered self evaluation form median 7.7 years after the operation. The revision rate for the prosthesis was low (3%). A frequency of short-term complications of 15% and of later surgical procedures of 20% was observed. The American Knee Society Score showed 65% excellent or good, 20% fair and 35% poor results. The results of the patient administered KOOS showed significant improvements for the subcategories ''symptoms'', ''pain", ''activities of daily living" and ''quality of life". The worst results were seen among patients with pre-arthritic patellofemoral pain syndrome. 7-8 years after patellofemoral arthroplasty survival of the prosthesis is good. The clinical result is unpredictable. Most patients can expect a reduction in their level of pain and a higher level of daily living activities. The level of sports and recreational activities did not increase, even among younger patients. Patients with patellofemoral pain before radiological signs of arthritis are present in the joint cannot expect a measurable effect from the operation.
- 4 June 2007
- Vol. 169 (23) , 2201-4
[Treatment of patellofemoral arthritis with patello-femoral arthroplasties].
Patellofemoral arthritis is a common entity and patellofemoral arthroplasties have been performed since the 1970s. However, follow-up studies are few, and the optimal indication for the operation has yet to be established. This study concentrates on the gains in patient-reported quality of life parameters achieved by the operation. Of 26 patients operated with 31 Richards Model Patella II patellofemoral arthroplasties, 17 patients with 20 arthroplasties were available for clinical review using two subjective/objective scoring systems and one patient administered self evaluation form median 7.7 years after the operation. The revision rate for the prosthesis was low (3%). A frequency of short-term complications of 15% and of later surgical procedures of 20% was observed. The American Knee Society Score showed 65% excellent or good, 20% fair and 35% poor results. The results of the patient administered KOOS showed significant improvements for the subcategories ''symptoms'', ''pain", ''activities of daily living" and ''quality of life". The worst results were seen among patients with pre-arthritic patellofemoral pain syndrome. 7-8 years after patellofemoral arthroplasty survival of the prosthesis is good. The clinical result is unpredictable. Most patients can expect a reduction in their level of pain and a higher level of daily living activities. The level of sports and recreational activities did not increase, even among younger patients. Patients with patellofemoral pain before radiological signs of arthritis are present in the joint cannot expect a measurable effect from the operation.
- 1 March 2002
- Published by Elsevier in Thrombosis Research
- Vol. 105 (6) , 477-480
Low molecular weight heparin (Innohep) as thromboprophylaxis in outpatients with a plaster cast
- 1 March 2002
- Published by Elsevier in Thrombosis Research
- Vol. 105 (6) , 477-480
Low molecular weight heparin (Innohep) as thromboprophylaxis in outpatients with a plaster cast